Detalhe da pesquisa
1.
Efficacy of a tetravalent dengue vaccine in children in Latin America.
N Engl J Med
; 372(2): 113-23, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25365753
2.
Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
N Engl J Med
; 371(7): 635-45, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25119609
3.
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.
Lancet
; 384(9951): 1358-65, 2014 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25018116
4.
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial.
Lancet
; 380(9853): 1559-67, 2012 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-22975340
5.
The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators' perception.
Pan Afr Med J
; 41: 242, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734313
6.
Medical countermeasures against henipaviruses: a review and public health perspective.
Lancet Infect Dis
; 22(1): e13-e27, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735799
7.
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.
Nat Med
; 10(4): 406-10, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15034567
8.
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Vaccine
; 39(51): 7357-7362, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799142
9.
A descriptive cross-sectional study of cholera at Kakuma and Kalobeyei refugee camps, Kenya in 2018.
Pan Afr Med J
; 37: 197, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33505566
10.
A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries.
Pilot Feasibility Stud
; 6: 24, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32082610
11.
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
N Engl J Med
; 354(1): 11-22, 2006 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16394298
12.
A review of Lassa fever vaccine candidates.
Curr Opin Virol
; 37: 105-111, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31472333
13.
Vaccine Update: Recent Progress With Novel Vaccines, and New Approaches to Safety Monitoring and Vaccine Shortage.
J Clin Pharmacol
; 58 Suppl 10: S123-S139, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30248195
14.
Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
Pediatr Infect Dis J
; 25(1): 12-8, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16395096
15.
Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya.
Am J Trop Med Hyg
; 75(1): 166-70, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16837726
16.
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
Lancet
; 364(9443): 1411-20, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15488216
17.
Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific.
Am J Trop Med Hyg
; 68(1): 97-101, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12556156
18.
Epidemiology of travelers' diarrhea: details of a global survey.
J Travel Med
; 11(4): 231-7, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15541226
19.
Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults.
Vaccine
; 32(49): 6683-91, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24950358
20.
WHO preferred product characteristics for new vaccines against tuberculosis.
Lancet Infect Dis
; 18(8): 828-829, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30064668